Thomas J. Magliery

Thomas J. Magliery, PhD, MBA, currently serves as the Director and Graduate Studies Chair of the Ohio State Biochemistry Program and is an Associate Professor in the Department of Chemistry & Biochemistry at The Ohio State University. Magliery co-founded Cogen Bioscience, Inc., where Thomas J. holds the positions of President and CEO, focusing on innovative antibody fragment development for cancer treatment. His previous roles include advisory positions at KORU Biopharma, Inc., and acting CEO and CSO at Elumenx, Inc., as well as executive roles at Enlyton, Ltd. Magliery’s academic background includes postdoctoral training at Yale University and graduate research at The Scripps Research Institute. Magliery holds an MBA from The Ohio State University, a PhD in Chemistry from the University of California, Berkeley, and an AB in Chemistry from Kenyon College.